Ego mechanisms of defense are associated with patients' preference of treatment modality independent of psychological distress in end-stage renal disease

Patient Preference and Adherence

Volumn 4, Issue , 2010, Pages 25-32

  Hyphantis, Thomas ^a   Katsoudas, Spiros ^b   Voudiclari, Sonia ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

DSQ; Ego mechanisms of defense; End stage renal disease; Hemodialysis; Peritoneal dialysis; Psychopathology

Indexed keywords

EID: 77954583933     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/ppa.s7796     Document Type: Article

References (52)

1. Kalo Z, Jaray J, Nagy J. Economic evaluation of kidney transplantation versus hemodialysis in patients with end stage renal disease in Hungary. Prog Transplant. 2001;11:188-193.
2. Winkelmayer WC, Weinstein MC, Mittleman MA, et al. Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making. 2002;22:417-430.
3. Kafkia T, Kourakos M, Lagkazali B, et al. European practice database: results from Greece. EDTNA ERCA J. 2005;31:43-48.
4. Nesrallah G, Mendelssohn DC. Modality options for renal replacement therapy: The integrated care concept revisited. Hemodial Int. 2006; 10:143-151.
5. Lee A, Gudex C, Povlsen JV, et al. Patients' views regarding choice of dialysis modality. Nephrol Dial Transplant. 2008;23:3953-3959.
6. National Board of Health, Danish Centre for Evaluation and Health Technology Assessment. Dialysis in chronic renal failure: a health technology assessment. København, Denmark: Danish Centre for Evaluation and Health Technology Assessment; 2006;8. Available at http://www.cemtv.dk/. Accessed on January 10, 2010.
7. Jassal SV, Krishna G, Mallick NP, et al. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant. 2002;17(3):474-477.
8. Mendelssohn DC, Mullaney SR, Jung B, et al. What do American nephologists think about dialysis modality selection? Am J Kidney Dis. 2001;37:22-29.
9. Thamer M, Hwang W, Fink NE, et al. US nephrologists' recommendation of dialysis modality: Results of a national survey. Am J Kidney Dis. 2000;36:1155-1165.
10. Christensen A, Wiebe J, Edwards D, et al. Body consciousness, illnessrelated impairment and patient adherence in Hemodialysis. J Consult Clin Psychol. 1996;64:147-152.
11. Poll IB, De-Nour AK. Locus of control and adjustment to chronic haemodialysis. Psychol Med. 1980;10:153-157.
12. Holley J, Barrington K, Hayes I. Patient factors and the influence of nephrologists, social workers and nurses on patient decisions to choose continuous peritoneal dialysis. Adv Perit Dial. 1991;7:108-110.
13. Coupe D. Making decisions about dialysis options: an audit of patients' views. EDTNA ERCA J. 1998;24:25-26, 31.
14. King K. Educational factors affecting modality selection: a National Kidney Foundation Study. EDTNA ERCA J. 1998;24:27-29.
15. Wuerth D, Finkelstein S, Schwrtz O, et al. Patients' descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Perit Dial Int. 2002;22:184-190.
16. Breckenridge D. Patients' perceptions of why, how and by whom dialysis treatment modality was chosen. ANNA J. 1997;24:313-321.
17. Vaillant GE, editor. Ego Mechanisms of Defense. A guide for clinicians and researchers. Washington DC: American Psychiatric Press; 1992.
18. Sartorius N, Jablensky A, Regier DA, Burke JD, Hirschfeld RMA, editors. Sources and Traditions of Classification in Psychiatry. Toronto, Canada: Hogrefe and Huber; 1990.
19. Hyphantis T, Kaltsouda A, Triantafillidis J, et al. Personality correlates of adherence to type 2 diabetes regimens. Int J Psychiatry Med. 2005; 35:103-107.
20. Hyphantis TN, Tsifetaki N, Siafaka V, et al. The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin Arthritis Rheum. 2007;37:81-92.
21. Paika V, Almyroudi A, Tomenson B, et al. Personality variables are associated with colorectal cancer patients' quality of life independent of psychological distress and disease severity. Psychooncology. 2009; DOI 10.1002pon.1563.
22. Hyphantis TN, Triantafillidis JK, Pappa S, et al. Defense mechanisms in inflammatory bowel disease. J Gastroenterol. 2005;40:24-30.
23. Bai M, Tomenson B, Creed F, et al. The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis. Scand J Rheumatol. 2009;38:419-430.
24. Derogatis LR. SCL-90-R: Administration, scoring, and procedure manual. 3rd Ed. Minneapolis, MN: National Computer Systems; 1994.
25. Recklitis CJ, Licht I, Ford J, et al. Screening adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R. Psychooncology. 2007;16:1046-1049.
26. Parker JC, Buckelew SP, Smarr KL, et al. Psychological screening in rheumatoid arthritis. J Rheumatology. 1990;17:1016-1021.
27. Donias S, Karastergiou A, Manos N. Standardization of the symptom checklist-90-R rating scale in a Greek population (in Greek with English abstract). Psychiatriki. 1991;2:42-48.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
29. Bond M. An empirical study of defense styles: the Defense Style Questionnaire. In: Vaillant GE, editors. Ego Mechanisms of Defense: A guide for clinicians and researchers. Washington DC: American Psychiatric Press; 1992:139-140.
30. Bond M. Empirical studies of defense style: relationships with psychopathology and change. Harv Rev Psychiatry. 2004;12:263-278.
31. Hyphantis T, Almyroudi A, Paika V, et al. Narcissistic rage: The Achilles' heel of the patient with chronic physical illness. Patient Prefer Adherence. 2009;3:239-250.
32. Altman DG. Practical Statistics for Medical Research. London, UK: Chapman and Hall; 1991:285.
33. United States Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1997.
34. Blake PG, Finkelstein FO. Why is the proportion of patients doing peritoneal dialysis declining in North America? Perit Dial Int. 2001;21:107-119.
35. Pereira BJG. Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int. 2000;57:351-365.
36. Little J, Irwin A, Marshall T, et al. Predicting a patient's choice of dialysis modality: experience in a United Kingdom renal department. Am J Kidney Dis. 2001;37:981-986.
37. Golper TA, Vonesh EF, Wolfson M, et al. The impact of pre-ESRD education on dialysis modality selection [abstract]. J Am Soc Nephrol. 2000;11:231A.
38. Fenton SA, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334-342.
39. Julius M, Kneisley JD, Carpentier-Alting P, et al. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study). Arch Intern Med. 1989;149:839-842.
40. Merkus MP, Jager KJ, Dekker FW, et al. Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis. 1997;29:584-592.
41. Jassal SV, Krishna G, Mallick NP, et al. Attitudes of British Isles nephrologists towards dialysis modality selection: A questionnaire study. Nephrol Dial Transplant. 2002;17:474-477.
42. Jung B, Blake PG, Mehta RL, et al. Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int. 1999;19: 263-268.
43. Mendelssohn DC, Mullaney SR, Jung B, et al. What do American nephologists think about dialysis modality selection? Am J Kidney Dis. 2001;37:22-29.
44. Rubin J, Kirchner K, Ray R, et al. Demographic factors associated with dialysis technique failures among patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med. 1985;145:1041-1045.
45. Nolph KD, Lindblad AS, Nova JW. Current concepts: continuous ambulatory peritoneal dialysis. N Engl J Med. 1988;24:1595-1600.
46. Zent R, Myers JE, Donald D, et al. Continuous ambulatory peritoneal dialysis: an option in the developing world? Perit Dial Int. 1994;14: 48-51.
47. Bond M. The development and properties of the Defense Style Questionnaire. In: Conte HR, Plutchik R, editors. Ego Defenses: Theory and measurement. New York, NY: Wiley; 1995:212.
48. Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967;15:641-685.
49. Vaillant GE. The clinical management of immature defences in the treatment of individuals with personality disorders. In: Vaillant GE, editor. Ego Mechanisms of Defense: A guide for clinicians and researchers. Washington DC: American Psychiatric Press; 1992:59-86.
50. Bond M. Empirical studies of defense style: relationships with psychopathology and change. Harv Rev Psychiatry. 2004;12:263-278.
51. Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
52. Kraemer HC, Stice E, Kazdin A, et al. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry. 2001;158:848-856.